Publications by authors named "Y Atsuta"
COVID-19 became a global pandemic in 2020 and significantly affected the activity of hematopoietic cell transplants (HCT) worldwide. Despite these challenges, a total of 28,793 transplants, including 18,518 allogeneic and 10,275 autologous transplants, were performed in 719 facilities in 2020 in the Asia-Pacific (AP) region. This represented a 5.
View Article and Find Full Text PDFArticle Synopsis
- * The research included 707 adults and found that the 5-year progression-free survival (PFS) rate was 18.8%, with overall survival at 22.0%, and identified key factors affecting outcomes, such as male sex, poor performance status, karyotype risk, and blasts in the blood.
- * These findings provide valuable insights into the prognosis and treatment strategies for R/R AML, influencing future
Article Synopsis
- The study compares outcomes of unrelated cord blood transplantation (UCBT) and haploidentical transplantation with posttransplant cyclophosphamide (PTCy-haplo) in patients without a matched donor, focusing on the impact of CD34 cell counts in cord blood.
- Data from 2014 to 2020 was analyzed, categorizing UCBT cases into those with high (≥0.84 × 10/kg) and low (<0.84 × 10/kg) CD34 cell counts, revealing better neutrophil engraftment in PTCy-haplo compared to both UCB groups.
- While UCB-H showed similar nonrelapse mortality (NRM) and overall survival